In a model of GBM-expressing CXCL12, Muller et al.39 modified epidermal growth factor receptor (EGFR)-III expressing chimeric antigen receptor (CAR) NK cells to overexpress CXCR4, showing improved migration and a decrease in tumor volume. Here, CXCL12 is linked to neoplasm.